HHS.gov/Recovery Updates

 

 

 

Implementation Summary

 

 

As of November 26, 2010

• Total HHS Recovery Funds Obligated (through grants and contracts): $116.8 Billion
• Total Gross Outlays (spent by recipients): $96.9 Billion
• Cumulative Recovery Act Medicaid FMAP State draw downs total about $77.2 billion.

Also see:

• Recovery Act Medicaid FMAP State Awards  
• Savings to States’ Prescription Drug (Part D) Costs
• All the HHS Recovery Weekly Financial and Activities Reports

Available Full Reports:

• HHS Recovery Weekly Financial and Activities Reports
• Medicaid FMAP Awards

Recent Major Activities

• State Fiscal Relief: CMS estimates that nearly $4 billion in fiscal relief to States has been provided through application of the ARRA FMAP increase when calculating State contributions for prescription drug costs for full-benefit dual eligible individuals enrolled in Medicare Part D by the end of October 2010. This recalculation due to ARRA significantly reduces each State’s monthly State contribution amount. The additional monthly fiscal relief provided to each State because of this recalculation due to the increase in FMAP provided by ARRA is equal to the difference between: the amount CMS initially would have billed the State based on the pre-ARRA FMAP rate for each State, and the adjusted bill the State receives as a result of the increase in the FMAP rate provided by ARRA. The difference is reported in the “Total Gross Outlays” column consistent with OMB guidance. These reductions in State contributions result in higher net federal outlays under the Part D program.

For more information about HHS Recovery Activities, see Announcements (chronological order) or Announcements by Topic.

This information has recently been updated, and is now available.